tiprankstipranks
Teva Pharmaceutical (TEVA)
NYSE:TEVA
US Market
TEVA
Teva Pharmaceutical
RESEARCH TOOLSreports
Want to see TEVA full AI Analyst Report?

Teva Pharmaceutical (TEVA) Ratios

7,711 Followers

Teva Pharmaceutical Ratios

TEVA's free cash flow for Q1 2026 was $0.50. For the 2026 fiscal year, TEVA's free cash flow was decreased by $ and operating cash flow was $0.16. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.01 1.04 0.98 1.02 1.05
Quick Ratio
 0.78 0.80 0.75 0.69 0.72
Cash Ratio
 0.28 0.26 0.26 0.26 0.24
Solvency Ratio
 0.08 0.07 -0.02 0.02 -0.03
Operating Cash Flow Ratio
 0.18 0.12 0.10 0.11 0.14
Short-Term Operating Cash Flow Coverage
 0.92 0.91 0.70 0.82 0.75
Net Current Asset Value
$ -18.27B$ -18.89B$ -21.05B$ -22.87B$ -23.36B
Leverage Ratios
Debt-to-Assets Ratio
 0.42 0.43 0.46 0.46 0.49
Debt-to-Equity Ratio
 2.05 2.20 3.36 2.68 2.76
Debt-to-Capital Ratio
 0.67 0.69 0.77 0.73 0.73
Long-Term Debt-to-Capital Ratio
 0.63 0.66 0.75 0.71 0.71
Financial Leverage Ratio
 4.87 5.15 7.32 5.79 5.64
Debt Service Coverage Ratio
 1.01 1.21 1.38 0.58 -0.09
Interest Coverage Ratio
 3.97 2.35 -0.32 0.42 -2.36
Debt to Market Cap
 0.40 0.48 0.71 1.70 2.10
Interest Debt Per Share
 15.50 15.92 16.82 18.93 20.26
Net Debt to EBITDA
 4.00 4.40 3.34 10.86 -20.28
Profitability Margins
Gross Profit Margin
51.98%51.79%48.74%48.25%46.72%
EBIT Margin
13.28%12.39%20.38%2.56%-14.96%
EBITDA Margin
19.04%18.20%26.78%9.83%-6.20%
Operating Profit Margin
19.38%12.50%-1.83%2.73%-14.72%
Pretax Profit Margin
7.92%7.17%-7.76%-3.93%-21.05%
Net Profit Margin
9.03%8.17%-9.91%-3.53%-16.39%
Continuous Operations Profit Margin
9.04%8.22%-11.84%-3.88%-16.74%
Net Income Per EBT
114.07%113.89%127.75%89.87%77.85%
EBT Per EBIT
40.87%57.39%423.43%-143.65%143.01%
Return on Assets (ROA)
3.90%3.46%-4.17%-1.29%-5.56%
Return on Equity (ROE)
20.79%17.83%-30.50%-7.45%-31.34%
Return on Capital Employed (ROCE)
12.62%7.90%-1.14%1.39%-6.75%
Return on Invested Capital (ROIC)
11.49%7.41%-1.07%1.30%-5.04%
Return on Tangible Assets
7.57%6.72%-8.29%-2.67%-12.16%
Earnings Yield
3.75%3.93%-6.58%-4.78%-24.16%
Efficiency Ratios
Receivables Turnover
 5.09 4.65 5.41 4.65 4.04
Payables Turnover
 3.19 3.29 3.85 3.15 4.21
Inventory Turnover
 2.61 2.62 2.82 2.04 2.07
Fixed Asset Turnover
 3.99 3.90 3.34 2.58 2.42
Asset Turnover
 0.43 0.42 0.42 0.36 0.34
Working Capital Turnover Ratio
 52.06 140.30 -5.51K 38.65 14.03
Cash Conversion Cycle
 97.24 106.87 102.09 141.67 179.71
Days of Sales Outstanding
 71.71 78.45 67.49 78.51 90.39
Days of Inventory Outstanding
 139.78 139.46 129.41 178.98 175.94
Days of Payables Outstanding
 114.25 111.03 94.81 115.82 86.61
Operating Cycle
 211.50 217.91 196.90 257.49 266.32
Cash Flow Ratios
Operating Cash Flow Per Share
 2.11 1.44 1.10 1.22 1.43
Free Cash Flow Per Share
 1.64 1.00 0.66 0.75 0.94
CapEx Per Share
 0.47 0.44 0.44 0.47 0.49
Free Cash Flow to Operating Cash Flow
 0.78 0.70 0.60 0.62 0.66
Dividend Paid and CapEx Coverage Ratio
 4.47 3.29 2.50 2.60 2.90
Capital Expenditure Coverage Ratio
 4.47 3.29 2.50 2.60 2.90
Operating Cash Flow Coverage Ratio
 0.14 0.09 0.07 0.07 0.07
Operating Cash Flow to Sales Ratio
 0.14 0.10 0.08 0.09 0.11
Free Cash Flow Yield
4.47%3.20%3.00%7.21%10.29%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 26.68 25.43 -15.21 -20.90 -4.14
Price-to-Sales (P/S) Ratio
 2.43 2.08 1.51 0.74 0.68
Price-to-Book (P/B) Ratio
 5.06 4.53 4.64 1.56 1.30
Price-to-Free Cash Flow (P/FCF) Ratio
 22.37 31.24 33.28 13.87 9.72
Price-to-Operating Cash Flow Ratio
 17.23 21.75 19.99 8.54 6.37
Price-to-Earnings Growth (PEG) Ratio
 0.01 -0.14 -0.08 0.27 <0.01
Price-to-Fair Value
 5.06 4.53 4.64 1.56 1.30
Enterprise Value Multiple
 16.76 15.82 8.96 18.36 -31.23
Enterprise Value
 55.63B 49.69B 39.71B 28.61B 28.88B
EV to EBITDA
 16.76 15.82 8.96 18.36 -31.23
EV to Sales
 3.19 2.88 2.40 1.81 1.94
EV to Free Cash Flow
 29.39 43.28 53.01 33.98 27.72
EV to Operating Cash Flow
 22.81 30.13 31.84 20.91 18.17
Tangible Book Value Per Share
 -9.78 -10.33 -12.24 -12.90 -13.79
Shareholders’ Equity Per Share
 7.19 6.88 4.75 6.71 7.03
Tax and Other Ratios
Effective Tax Rate
 -0.14 -0.15 -0.53 0.01 0.20
Revenue Per Share
 15.08 15.02 14.63 14.16 13.45
Net Income Per Share
 1.36 1.23 -1.45 -0.50 -2.20
Tax Burden
 1.14 1.14 1.28 0.90 0.78
Interest Burden
 0.60 0.58 -0.38 -1.54 1.41
Research & Development to Revenue
 0.06 0.06 0.06 0.06 0.06
SG&A to Revenue
 0.23 0.23 0.22 0.07 0.08
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 1.55 1.16 -0.64 -2.22 -0.66
Currency in USD